Pharmalogical Consideration of Infectious Disease and Agents

Pandemic, epidemic and endemic infectious diseases are united by a standard problem: how do we quickly and cost-effectively determine potential pharmacological arbitration to treat infections? The growing accessibility of parasite genome data provides the basis for developing methods to prioritize, a priori potential drug targets and analyze the pharmacological landscape of an infectious disease. Infectious diseases create totally different threats to different constituencies and thus are often treated as separate problems by governments, businesses, philanthropies and research funders: neglected diseases are treated as world health problems; emerging and pandemic diseases  as public health issues; and bio-defence as a national security issue.

    Related Conference of Pharmalogical Consideration of Infectious Disease and Agents

    May 30-31, 2024

    World congress on Immunology and Virology Diseases

    Vienna, Austria
    August 01-02, 2024

    44th Global Summit and Expo on Vaccines & Immunology

    Montreal, Canada
    September 09-10, 2024

    4th International Conference on Vaccine Research

    Madrid, Spain
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France

    Pharmalogical Consideration of Infectious Disease and Agents Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in